WASHINGTON, July 23, 2020 /PRNewswire/ -- Recent
articles in Experimental Biology and Medicine highlight new
advances in COVID-19 biology and treatment. In an effort to provide
the scientific community with important information on COVID-19, at
the rapid pace required to protect our global health care workers
and bring useful therapies to end the pandemic, manuscripts are
being handled at an accelerated rate. To accomplish this our EBM
Editor-in-Chief is handling all COVID-19 manuscripts to make sure
they receive a thorough but accelerated review. The Publisher of
EBM, SAGE, is making sure that accepted COVID-19 manuscripts are
processed rapidly, immediately available via Online First, and are
open access. EBM will continue to inform the scientific community
and the public of these published articles through Press
Releases.
EBM has recently accepted three Minireviews on Coronavirus
SARS-CoV-2 genome structure, clinical trials, and outstanding
issues. The Minireviews cover the value of chest computed
tomography (CT) (Wong et al, 2020), the multiple organ pathology
found in COVID-19 patients (Aferwerky, 2020), and the host immune
response and its dysregulation caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) (Upadhyay et al, 2020). We have
also recently published an important Commentary regarding the
possibility of transmission of SARS-CoV-2 via sweat (Propper,
2020).
The Corresponding Authors of these articles had the following
comments on the importance of their contribution. Dr. Hong Liu in the Advanced Medical Imaging Center
and School of Electrical and Computer Engineering at the
University of Oklahoma in Norman, OK
(USA) speaking of his article 'The role of chest computed
tomography in the management of COVID-19: A review of results and
recommendations
(https://journals.sagepub.com/doi/pdf/10.1177/1535370220938315)'
said, "The impact of the COVID-19
pandemic has been felt worldwide. This mini-review compiles the
various agency and expert recommendations, together with studies
published thus far to provide a thorough understanding of the
role of chest CT in the detection and management
of COVID-19."
Dr. Henok Afewerky in the Department of Neurobiology at Huazhong
University of Science and Technology in Wuhan (China), discussing his article ' Pathology and
pathogenicity of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2)
(https://journals.sagepub.com/doi/pdf/10.1177/1535370220942126)'
said, "The coronavirus pandemic is
having an unprecedented impact on lives across the world. To assist
efforts to contain and mitigate the rapidly evolving COVID-19
either-or should a similar viral plague occur in the future, a
continuous critical survey of studies will be vital to addressing
the global crisis."
Dr. Mohd Nazam Ansari in the
Department of Pharmacology & Toxicology, College of Pharmacy,
at Prince Sattam Bin Abdulaziz University (Saudi Arabia), speaking of his article 'Role
of inflammatory markers in corona virus disease (COVID-19)
patients: A review
(https://journals.sagepub.com/doi/pdf/10.1177/1535370220939477)'
said, "This review provides a short
overview on the pathophysiology of COVID-19 and role of activated
inflammatory markers. Cytokine storm syndrome in critically ill
COVID-19 patients presented with high inflammatory mediators,
systemic inflammation, and multiple organ failure. Among various
inflammatory mediators, the level of interleukins (IL-2, IL-7,
IL-10), G-CSF, MIP1A, MCP1, and TNF-α was reported to be higher in
critically ill patients. Understanding this molecular mechanism of
ILs, T cells, and dendritic cells will be helpful in designing
vaccines and novel drugs for the treatment of COVID-19
infection."
Dr. Ruth Propper in the
Department of Psychology at Montclair State
University in Montclair, NJ
(USA) discussing her article entitled 'Is sweat a possible route of
transmission of SARS-CoV-2?
(https://journals.sagepub.com/doi/pdf/10.1177/1535370220935409)'
said, "Given the high health burden
of Sars-CoV-2 and the many unknowns associated with the disease,
research on how it transmits is important for public health.
Ultimately, knowledge of how transmission occurs - by ruling out or
including routes - can be translated into practical action to help
people be safe."
Dr. Steven R. Goodman,
Editor-in-Chief of Experimental Biology and Medicine,
said, "EBM will continue to inform
the scientific community and the public of our published COVID-19
articles through Press Releases. To do their best work for the
Global Community, researchers need rapid dissemination of COVID-19
studies and ideas from the worldwide scientific community. The
public needs the same to make safe choices for themselves and their
family members, during the Pandemic."
Experimental Biology and Medicine is a global journal
dedicated to the publication of multidisciplinary and
interdisciplinary research in the biomedical sciences. The journal
was first established in 1903. Experimental Biology and
Medicine is the journal of the Society of Experimental Biology
and Medicine. To learn about the benefits of society membership,
visit www.sebm.org. For anyone interested in publishing in the
journal, please visit http://ebm.sagepub.com.
Related Images
logo.png
Logo
View original content to download
multimedia:http://www.prnewswire.com/news-releases/further-advancements-in-covid-19-prevention-and-treatment-301099117.html
SOURCE Experimental Biology and Medicine